The potential of virtual reality-based therapy for serious mental disorders
Pharmaceutical Technology
AUGUST 12, 2022
Anti-psychotics come with the risk of side effects such as drowsiness, agitation and blurred vision, so virtual reality (VR) technologies that can enhance recovery without anti-psychotics are an attractive option. In 2020, OxfordVR secured a $12.5m Series A funding from Optum Ventures, supported by Luminous Ventures.
Let's personalize your content